Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| regulatory T cell | 8 studies | 19% ± 5% | |
| glutamatergic neuron | 6 studies | 40% ± 24% | |
| classical monocyte | 4 studies | 19% ± 2% | |
| non-classical monocyte | 4 studies | 21% ± 5% | |
| neuron | 4 studies | 21% ± 4% | |
| Mueller cell | 4 studies | 25% ± 7% | |
| GABAergic neuron | 4 studies | 43% ± 14% | |
| interneuron | 4 studies | 38% ± 19% | |
| CD4-positive, alpha-beta T cell | 3 studies | 25% ± 6% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 24% ± 6% | |
| retinal ganglion cell | 3 studies | 51% ± 14% | |
| retina horizontal cell | 3 studies | 21% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 40% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 2806.46 | 2635 / 2642 | 100% | 20.48 | 704 / 705 |
| lung | 99% | 936.57 | 575 / 578 | 97% | 6.08 | 1119 / 1155 |
| breast | 99% | 667.04 | 455 / 459 | 93% | 5.40 | 1041 / 1118 |
| prostate | 98% | 536.16 | 239 / 245 | 92% | 5.67 | 462 / 502 |
| thymus | 99% | 572.75 | 645 / 653 | 88% | 4.27 | 535 / 605 |
| skin | 93% | 834.13 | 1687 / 1809 | 94% | 13.18 | 443 / 472 |
| ovary | 99% | 576.63 | 179 / 180 | 87% | 3.42 | 373 / 430 |
| uterus | 99% | 892.17 | 168 / 170 | 79% | 4.05 | 364 / 459 |
| esophagus | 82% | 532.36 | 1183 / 1445 | 93% | 5.44 | 170 / 183 |
| bladder | 100% | 566.05 | 21 / 21 | 67% | 3.35 | 338 / 504 |
| intestine | 89% | 559.66 | 855 / 966 | 74% | 3.39 | 392 / 527 |
| kidney | 71% | 301.99 | 63 / 89 | 87% | 6.37 | 782 / 901 |
| stomach | 57% | 286.84 | 203 / 359 | 84% | 4.52 | 241 / 286 |
| adrenal gland | 48% | 159.19 | 123 / 258 | 82% | 10.10 | 188 / 230 |
| pancreas | 21% | 66.67 | 69 / 328 | 89% | 4.66 | 159 / 178 |
| blood vessel | 100% | 1570.05 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 14.66 | 29 / 29 |
| adipose | 100% | 868.07 | 1201 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 627.90 | 240 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 97% | 1283.90 | 903 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 89% | 15.49 | 71 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 84% | 4.56 | 38 / 45 |
| heart | 80% | 388.04 | 691 / 861 | 0% | 0 | 0 / 0 |
| muscle | 60% | 210.97 | 484 / 803 | 0% | 0 | 0 / 0 |
| liver | 18% | 54.57 | 40 / 226 | 42% | 1.54 | 172 / 406 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0051260 | Biological process | protein homooligomerization |
| GO_0006620 | Biological process | post-translational protein targeting to endoplasmic reticulum membrane |
| GO_0051291 | Biological process | protein heterooligomerization |
| GO_0072380 | Cellular component | TRC complex |
| GO_0016020 | Cellular component | membrane |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0060090 | Molecular function | molecular adaptor activity |
| GO_0030544 | Molecular function | Hsp70 protein binding |
| Gene name | SGTB |
| Protein name | Small glutamine rich tetratricopeptide repeat co-chaperone beta Small glutamine-rich tetratricopeptide repeat-containing protein beta (Beta-SGT) (Small glutamine-rich protein with tetratricopeptide repeats 2) |
| Synonyms | SGT2 |
| Description | FUNCTION: Co-chaperone that binds directly to HSC70 and HSP70 and regulates their ATPase activity. . |
| Accessions | ENST00000381007.9 D6RFW1 Q96EQ0 ENST00000506816.1 |